4dpe
From Proteopedia
(Difference between revisions)
| (3 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | {{STRUCTURE_4dpe| PDB=4dpe | SCENE= }} | ||
| - | ===Structure of MMP3 complexed with a platinum-based inhibitor.=== | ||
| - | {{ABSTRACT_PUBMED_23660647}} | ||
| - | == | + | ==Structure of MMP3 complexed with a platinum-based inhibitor.== |
| - | [[http://www.uniprot.org/uniprot/MMP3_HUMAN MMP3_HUMAN | + | <StructureSection load='4dpe' size='340' side='right'caption='[[4dpe]], [[Resolution|resolution]] 1.96Å' scene=''> |
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[4dpe]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4DPE OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4DPE FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.96Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=NGH:N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL+HYDROXAMIC+ACID'>NGH</scene>, <scene name='pdbligand=PT:PLATINUM+(II)+ION'>PT</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4dpe FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4dpe OCA], [https://pdbe.org/4dpe PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4dpe RCSB], [https://www.ebi.ac.uk/pdbsum/4dpe PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4dpe ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Disease == | ||
| + | [https://www.uniprot.org/uniprot/MMP3_HUMAN MMP3_HUMAN] Defects in MMP3 are the cause of susceptibility to coronary heart disease type 6 (CHDS6) [MIM:[https://omim.org/entry/614466 614466]. A multifactorial disease characterized by an imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. Decreased capacity of the coronary vessels is often associated with thickening and loss of elasticity of the coronary arteries. Note=A polymorphism in the MMP3 promoter region is associated with the risk of coronary heart disease and myocardial infarction, due to lower MMP3 proteolytic activity and higher extracellular matrix deposition in atherosclerotic lesions.<ref>PMID:8662692</ref> <ref>PMID:12477941</ref> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/MMP3_HUMAN MMP3_HUMAN] Can degrade fibronectin, laminin, gelatins of type I, III, IV, and V; collagens III, IV, X, and IX, and cartilage proteoglycans. Activates procollagenase. | ||
| - | == | + | ==See Also== |
| - | [[ | + | *[[Matrix metalloproteinase 3D structures|Matrix metalloproteinase 3D structures]] |
| - | + | == References == | |
| - | == | + | <references/> |
| - | + | __TOC__ | |
| - | + | </StructureSection> | |
| - | + | ||
| - | + | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: Arnesano | + | [[Category: Arnesano F]] |
| - | [[Category: Belviso | + | [[Category: Belviso BD]] |
| - | [[Category: Calderone | + | [[Category: Calderone V]] |
| - | [[Category: Caliandro | + | [[Category: Caliandro R]] |
| - | [[Category: Natile | + | [[Category: Natile G]] |
| - | [[Category: Siliqi | + | [[Category: Siliqi D]] |
| - | + | ||
| - | + | ||
Current revision
Structure of MMP3 complexed with a platinum-based inhibitor.
| |||||||||||
